Toxoplasma gondii is a worldwide distributed protozoan parasite. This apicomplexan
parasite infects one-third of the population worldwide, causing toxoplasmosis, considered …

Toxoplasmosis is a parasitic disease affecting human, livestock and cat. Prophylactic
strategies would be ideal to prevent infection. In a One Health vaccination approach, the …

Toxoplasma gondii, a specialized intracellular parasite, causes a widespread zoonotic
disease and is a severe threat to social and economic development. There is a lack of …

The study aimed to investigate the immunomodulatory effects of propranolol hydrochloride
(PRO) in combination with chitosan nanoparticles (CS NPs) as an adjuvant to develop an …

Despite recent major advances in developing effective vaccines against toxoplasmosis,
finding new protective vaccination strategies remains a challenging and elusive goal as it is …

Toxoplasma gondii is an intracellular apicomplexan parasite, which can cause a serious
infectious disease in pregnant women and immunocompromised individuals. Therefore, the …

Current study deals with a novel multi-epitope vaccine designed in silico and its confirmation
experiments for potential efficacy in BALB/c mice. Major histocompatibility complex (MHC) …

Caused by Toxoplasma gondii, toxoplasmosis has aroused great threats to public health
around the world. So far, no effective vaccine or drug is commercially available, and the …

The causative agent of toxoplasmosis, Toxoplasma gondii (T. gondii), is able to influence the
health of humans and other vertebrates. Toxoplasma may cause severe illness in the fetus …

Toxoplasma gondii (T. gondii) can infect almost all warm-blooded animals and is a major
threat to global public health. Currently, there is no effective drug or vaccine for T. gondii. In …